Announcements Trials
Browse Landscape

Phase

Phase 2 13Phase 1 8Phase 1/2 5Phase EARLY_PHASE1 3Phase 3 2Phase NA 1Phase 4 1

Status

Recruiting 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Breast Neoplasms 182Neoplasms 115Prostatic Neoplasms 103Multiple Myeloma 85Glioblastoma 82Pancreatic Neoplasms 75Glioma 65Brain Neoplasms 60Lung Neoplasms 58Head and Neck Neoplasms 57Melanoma 54Colorectal Neoplasms 54Carcinoma, Non-Small-Cell Lung 53Leukemia, Myeloid, Acute 51Carcinoma, Hepatocellular 50Squamous Cell Carcinoma of Head and Neck 46Recurrence 46Ovarian Neoplasms 45Lymphoma 39Lymphoma, Non-Hodgkin 37Lymphoma, B-Cell 36Sarcoma 35Stomach Neoplasms 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 34Neoplasm Metastasis 33Solid Tumor 31Hematologic Neoplasms 31Carcinoma, Renal Cell 30Polycystic Ovary Syndrome 27Burkitt Lymphoma 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Advanced Pancreatic Cancer × Clear all
NCT07416240 2026-02-18

Exploratory Clinical Study of Claudin18.2-Targeted Activated DC and CAR-T Therapy in Advanced Pancreatic Cancer.

Hainan Cancer Hospital

Phase EARLY_PHASE1 Recruiting
10 enrolled
Gastrointestinal

Advanced Pancreatic Cancer

NCT05916261 2023-10-26

Personalized Tumor Vaccines and Pabolizumab in Patients With Advanced Pancreatic Cancer

Ruijin Hospital

Phase EARLY_PHASE1 Recruiting
54 enrolled
Gastrointestinal

Advanced Pancreatic Cancer

NCT05438797 2022-06-30

The Safety and Efficacy of Specific TIL-TCM Cells for Advanced Relapse-refractory or Metastatic Pancreatic Cancer

Jinling Hospital, China

Phase EARLY_PHASE1 Unknown
3 enrolled
Gastrointestinal

Advanced Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡